Mechanisms of Tumor Growth and Metastasis in Head and Neck Squamous Cell Carcinoma

American Cancer Society: Cancer Facts & Figures 2007. Atlanta 2007, http://www.cancer.org/docroot/stt/stt_0.asp

Chin D, Boyle GM, Porceddu S, et al.: Head and neck cancer: past, present and future. Expert Rev Anticancer Ther 2006, 6:1111–1118

Beasley NJ, Prevo R, Banerji S, et al.: Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 2002, 62:1315–1320

Young MR: Protective mechanisms of head and neck squamous cell carcinomas from immune assault. Head Neck 2006, 28:462–470

Xie M, Zhou L, Hu T, Yao M: Intratumoral delivery of paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres for Hep-2 laryngeal squamous cell carcinoma xenografts. Anticancer Drugs 2007, 18:459–466

Slaughter DP, Southwick HW, Smejkal W: Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953, 6:963–968

Braakhuis BJ, Leemans CR, Brakenhoff RH: Expanding fields of genetically altered cells in head and neck squamous carcinogenesis. Semin Cancer Biol 2005, 15:113–120

Neville BW, Day TA: Oral cancer and precancerous lesions. CA Cancer J Clin 2002, 52:195–215

Epstein JB, Zhang L, Rosin M: Advances in the diagnosis of oral premalignant and malignant lesions. J Can Dent Assoc 2002, 68:617–621

O-Charoenrat P, Rhys-Evans P, Eccles SA: Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer 2001, 92:556–568

Uno M, Otsuki T, Kurebayashi J, et al.: Anti-HER2-antibody enhances irradiation-induced growth inhibition in head and neck carcinoma. Int J Cancer 2001, 94:474–479

Califano J, van der Rieth P, Westra W, et al.: Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996, 56:2488–2492

Sanz-Ortega J, Valor C, Saez MC, et al.: 3p21, 5q21, 9p21 and 17p13 allelic deletions accumulate in the dysplastic spectrum of laryngeal carcinogenesis and precede malignant transformation. Histol Histopathol 2003, 18:1053–1057

Ishii H, Wang Y, Huebner K: A Fhit-ing role in the DNA damage checkpoint response. Cell Cycle 2007, 6:1044–1048

Kresty LA, Mallery SR, Knobloch TJ, et al.: Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia. Cancer Res 2002, 62:5295–5300

Tsantoulis PK, Kastrinakis NG, Tourvas AD, et al.: Advances in the biology of oral cancer. Oral Oncol 2007, 43:523–534

Ishwad CS, Shuster M, Bockmuhl U, et al.: Frequent allelic loss and homozygous deletion in chromosome band 8p23 in oral cancer. Int J Cancer 1999, 80:25–31

Gollin SM: Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head Neck 2001, 23:238–253

Califano J, Westra WH, Meininger G, et al.: Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res 2000, 6:347–352

Zimmermann M, Zouhair A, Azria D, Ozsahin M: The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications. Radiat Oncol 2006, 1:11

Rosin MP, Cheng X, Poh C, et al.: Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res 2000, 6:357–362

Gupta RA, Tejada LV, Tong BJ, et al.: Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer. Cancer Res 2003, 63:906–911

Stoeltzing O, Ahmad SA, Liu W, et al.: Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors. Cancer Res 2003, 63:3370–3377

Zhang L, Yang N, Park JW, et al.: Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Cancer Res 2003, 63:3403–3412

Vinals F, Pouyssegur J: Transforming growth factor β1 (TGF-β1) promotes endothelial cell survival during in␣vitro angiogenesis via an autocrine mechanism implicating TGF-α signaling. Mol Cell Biol 2001, 21:7218–7230

Rofstad EK, Halsor EF: Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. Cancer Res 2000, 60:4932–4938

Tsuda S, Ohtsuru A, Yamashita S, et al.: Role of c-Fyn in FGF-2-mediated tube-like structure formation by murine brain capillary endothelial cells. Biochem Biophys Res Commun 2002, 290:1354–1360

Roeckl W, Hecht D, Sztajer H, et al.: Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2. Exp Cell Res 1998, 241:161–170

Benefield J, Petruzzelli GJ, Fowler S, et al.: Regulation of the steps of angiogenesis by human head and neck squamous cell carcinomas. Invasion Met 1996, 16:291–301

Takahashi T, Kalka C, Masuda H, et al.: Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999, 5:434–438

Shirakawa K, Furuhata S, Watanabe I, et al.: Induction of vasculogenesis in breast cancer models. Br J Cancer 2002, 87:1454–1461

Young MRI, Schmidt-Pak A, Wright MA, et al.: Mechanisms of immune suppression in patients with head and neck cancer: presence of immune suppressive CD34+ cells in cancers that secrete granulocyte-macrophage colony-stimulating factor. Clin Cancer Res 1995, 1:95–103

Young MR: Tumor skewing of CD34+ progenitor cell differentiation into endothelial cells. Int J Cancer 2004, 109:516–524

Schuch G, Heymach JV, Nomi M, et al.: Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells. Cancer Res 2003, 63:8345–8350

Melani C, Stoppacciaro A, Foroni C, et al.: Angiopoietin decoy secreted at tumor site impairs tumor growth and metastases by inducing local inflammation and altering neoangiogenesis. Cancer Immunol Immunother 2004, 53:600–608

Young MRI, Petruzzelli G, Kolesiak K, et al.: Human squamous cell carcinomas of the head and neck chemoattract immune suppressive CD34+ progenitor cells. Human Immunol 2001, 62:332–341

Aiuti A, Webb IJ, Bleul C, et al.: The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 1997, 185:111–120

Schofield KP, Rushton G, Humphries MJ, et al.: Influence of interleukin-3 and other growth factors on α4β1 integrin-mediated adhesion and migration of human hematopoietic progenitor cells. Blood 1997, 90:1858–1866

Isner JM, Asahara T: Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 1999, 103:1231–1236

Becker MT, Shores CG, Yu KK, Yarbrough WG: Molecular assay to detect metastatic head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004, 130:21–27

Puri SK, Fan CY, Hanna E: Significance of extracapsular lymph node metastases in patients with head and neck squamous cell carcinoma. Curr Opin Otolaryngol Head Neck Surg 2003, 11:119–123

Dunne AA, Muller HH, Eisele DW, et al.: Meta-analysis of the prognostic significance of perinodal spread in head and neck squamous cell carcinomas (HNSCC) patients. Eur J Cancer 2006, 42:1863–1868

Takes RP: Staging of the neck in patients with head and neck squamous cell cancer: imaging techniques and biomarkers. Oral Oncol 2004, 40:656–667

Cueni LN, Detmar M: New insights into the molecular control of the lymphatic vascular system and its role in disease. J Invest Dermatol 2006, 126:2167–2177

Kajiya K, Hirakawa S, Ma B, et al.: Hepatocyte growth factor promotes lymphatic vessel formation and function. EMBO J 2005, 24:2885–2895

Gale NW, Thurston G, Hackett SF, et al.: Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell 2002, 3:411–423

Zeng Y, Opeskin K, Goad J, Williams ED: Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis. Cancer Res 2006, 66:9566–9575

Giaccone G: The potential of antiangiogenic therapy in non-small cell lung cancer. Clin Cancer Res 2007, 13:1961–1970

Ristimaki A, Narko K, Enholm B, et al.: Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 1998, 273:8413–8418

Sakakura K, Chikamatsu K, Takahashi K, et al.: Maturation of circulating dendritic cells and imbalance of T-cell subsets in patients with squamous cell carcinoma of the head and neck. Cancer Immunol Immunother 2006, 55:151–159

Ferris RL, Hunt JL, Ferrone S: Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance. Immunol Res 2005, 33:113–133

Whiteside TL: Immunobiology of head and neck cancer. Cancer Metastasis Rev 2005, 24:95–105

Young MRI, Wright MA, Lozano Y, et al.: Mechanisms of immune suppression in patients with head and neck cancer: influence on the immune infiltrate of the cancer. Int J Cancer 1996, 67:333–338

Lu SL, Reh D, Li AG, et al.: Overexpression of transforming growth factor beta1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation. Cancer Res 2004, 64:4405–4410

Cross DS, Platt JL, Juhn SK, et al.: Administration of a prostaglandin synthetase inhibitor associated with an increased immune cell infiltrate in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1992, 118:526–528

Kim JW, Wieckowski E, Taylor DD, et al.: Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clin Cancer Res 2005, 11:1010–1020

Schaefer C, Kim GG, Albers A, et al.: Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer. Br J Cancer 2005, 92:913–920

Lathers DMR, Achille NJ, Young MRI: Incomplete Th2 skewing of cytokines in plasma of patients with squamous cell carcinoma of the head and neck. Hum Immunol 2003, 64:1160–1166

Dunn GP, Old LJ, Schreiber RD: The immunobiology of cancer immunosurveillance and immunoediting. Immunity 2004, 21:137–148

Shakhar G, Blumenfeld B: Glucocorticoid involvement in suppression of NK activity following surgery in rats. J Neuroimmunol 2003, 138:83–91

Merrick A, Errington F, Milward K, et al.: Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naive T-cell priming. Br J Cancer 2005, 92:1450–1458

Crews FT, Bechara R, Brown LA, et al.: Cytokines and alcohol. Alcohol Clin Exp Res 2006, 30:720–730

Garavello W, Ciardo A, Spreafico R, Gaini RM: Risk factors for distant metastases in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2006, 132:762–766

Vaidya AM, Petruzzelli GJ, Clark J, Emami B: Patterns of spread in recurrent head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 2001, 125:393–396

Colnot DR, Nieuwenhuis EJ, Kuik DJ, et al.: Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients. Clin Cancer Res 2004, 10:7827–7833

Kowalski LP, Carvalho AL, Martins Priante AV, Magrin J: Predictive factors for distant metastasis from oral and oropharyngeal squamous cell carcinoma. Oral Oncol 2005, 41:534–541

Adelson RT, Ducic Y: Metastatic head and neck carcinoma to a percutaneous endoscopic gastrostomy site. Head Neck 2005, 27:339–343

Liotta LA, Vembu D, Saini RK, Boone C: In vivo monitoring of the death rate of artificial murine pulmonary micrometastases. Cancer Res 1978, 38:1231–1236

Ellis LM, Fidler IJ: Angiogenesis and metastasis. Eur J Cancer 1996, 32A:2451–2460

Fidler IJ: The pathogenesis of cancer metastasis: the ‹seed and soil’ hypothesis revisited. Nat Rev Cancer 2003, 3:453–458

Mehlen P, Puisieux A: Metastasis: a question of life or death. Nat Rev Cancer 2006, 6:449–458

Weigelt B, Peterse JL, van’t Veer LJ: Breast cancer metastasis: markers and models. Nat Rev Cancer 2005, 5:591–602

Gangnus R, Langer S, Breit E, et al.: Genomic profiling of viable and proliferative micrometastatic cells from early-stage breast cancer patients. Clin Cancer Res 2004, 10:3457–3464

Xi L, Nicastri DG, El Hefnawy T, et al.: Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers. Clin Chem 2007, 53:1206–1215

Molling JW, Langius JA, Langendijk JA, et al.: Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma. J Clin Oncol 2007, 25:862–868

Scher RL: Role of nitric oxide in the development of distant metastasis from squamous cell carcinoma. Laryngoscope 2007, 117:199–209